Journal article
Are NKT cells a useful predictor of COVID-19 severity?
HF Koay, NA Gherardin, THO Nguyen, W Zhang, JR Habel, R Seneviratna, F James, NE Holmes, OC Smibert, CL Gordon, JA Trubiano, K Kedzierska, DI Godfrey
Immunity | Published : 2022
Related Projects (3)
Grants
Awarded by University of Melbourne
Funding Acknowledgements
We acknowledge all DRASTIC (The use of cytokines as a preDictoR of disease Severity in criTically Ill Covid-patients) investigators from Austin Health and thank the participants involved. This work was supported by the Victorian Government MRFF award (#2005544) to K.K. and D.I.G. K.K. and D.I.G. were supported by the Australian National Health and Medical Research Council (NHMRC) Leadership Investigator Grants #1173 871 and #2008913, respectively; H.-F.K. and C.L.G. were supported by NHMRC Early Career Fellowships #1160333 and #GNT1160963 respectively; N.A.G. by an Australian Research Council DECRA (DE210100705), and T.H.O.N. by a NHMRC Emerging Leadership Level 1 Investigator Grant (#1194036). J.R.H. and W.Z. were supported by Melbourne International Research Scholarships (MIRS) from the University of Melbourne. Experiments conformed to the Declaration of Helsinki Principles and the Australian National Health and Medical Research Council Code of Practice. Written informed consent was obtained from all donors prior to the study. The study was approved by the Austin Health (HREC/63201/Austin-2020) and the University of Melbourne (#2057366.1 and #2056901.1) Human Research Ethics Committees.